{{Rsnum
|rsid=16899974
|Gene=AGXT2
|Chromosome=5
|position=34998772
|Orientation=plus
|GMAF=0.2383
|Gene_s=AGXT2
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 4.4 | 33.6 | 61.9
| HCB | 12.4 | 50.4 | 37.2
| JPT | 22.1 | 49.6 | 28.3
| YRI | 0.0 | 8.8 | 91.2
| ASW | 1.8 | 10.5 | 87.7
| CHB | 12.4 | 50.4 | 37.2
| CHD | 19.6 | 56.1 | 24.3
| GIH | 4.0 | 43.6 | 52.5
| LWK | 0.0 | 7.3 | 92.7
| MEX | 6.9 | 43.1 | 50.0
| MKK | 0.6 | 17.3 | 82.1
| TSI | 6.9 | 36.6 | 56.4
| HapMapRevision=28
}}{{PMID Auto
|PMID=24159190
|Title=Genome-wide association study on dimethylarginines reveals novel AGXT2 variants associated with heart rate variability but not with overall mortality
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}